
Valerie Lynn Woodward
Examiner (ID: 335, Phone: (571)270-1479 , Office: P/3771 )
| Most Active Art Unit | 3771 |
| Art Unit(s) | 3771, 3785 |
| Total Applications | 995 |
| Issued Applications | 694 |
| Pending Applications | 59 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13729339
[patent_doc_number] => 20180369137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Natural Lubricant
[patent_app_type] => utility
[patent_app_number] => 16/018697
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/018697 | Natural Lubricant | Jun 25, 2018 | Abandoned |
Array
(
[id] => 16007459
[patent_doc_number] => 20200178572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => MICROWAVE PROCESSING METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/623367
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623367 | MICROWAVE PROCESSING METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS | Jun 18, 2018 | Abandoned |
Array
(
[id] => 14881489
[patent_doc_number] => 10420763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Sublingual apomorphine
[patent_app_type] => utility
[patent_app_number] => 16/005105
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10087
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005105 | Sublingual apomorphine | Jun 10, 2018 | Issued |
Array
(
[id] => 17168664
[patent_doc_number] => 20210322334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => CHITOSAN GELS (A) CONTAINING METAL NANOPARTICLES OF COPPER, SILVER AND ANTIBIOTICS (CIPROFLOXACIN, CEFOTAXIME, GENTAMICIN AND CLOXACILLIN)
[patent_app_type] => utility
[patent_app_number] => 16/973000
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973000 | CHITOSAN GELS (A) CONTAINING METAL NANOPARTICLES OF COPPER, SILVER AND ANTIBIOTICS (CIPROFLOXACIN, CEFOTAXIME, GENTAMICIN AND CLOXACILLIN) | Jun 6, 2018 | Abandoned |
Array
(
[id] => 13465195
[patent_doc_number] => 20180284140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => METHODS AND APPARATUSES FOR PREDICTING THE EFFECTS OF ERYTHROPOIESIS STIMULATING AGENTS, AND FOR DETERMINING A DOSE TO BE ADMINISTERED
[patent_app_type] => utility
[patent_app_number] => 16/000198
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000198 | METHODS AND APPARATUSES FOR PREDICTING THE EFFECTS OF ERYTHROPOIESIS STIMULATING AGENTS, AND FOR DETERMINING A DOSE TO BE ADMINISTERED | Jun 4, 2018 | Abandoned |
Array
(
[id] => 15204399
[patent_doc_number] => 20190364886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => BIOCIDE SYSTEM WITH PASSIVE DISPENSER
[patent_app_type] => utility
[patent_app_number] => 15/992387
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992387 | BIOCIDE SYSTEM WITH PASSIVE DISPENSER | May 29, 2018 | Abandoned |
Array
(
[id] => 15708489
[patent_doc_number] => 20200101010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => SUBLINGUAL FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID WITH CITRIC ACID, SODIUM BICARBONATE, AND L-THEANINE FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 16/617880
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617880 | SUBLINGUAL FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID WITH CITRIC ACID, SODIUM BICARBONATE, AND L-THEANINE FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION | May 29, 2018 | Abandoned |
Array
(
[id] => 13424775
[patent_doc_number] => 20180263930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 15/987011
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987011 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | May 22, 2018 | Abandoned |
Array
(
[id] => 13424773
[patent_doc_number] => 20180263929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 15/986992
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986992 | Dosage regimen of an S1P receptor modulator | May 22, 2018 | Issued |
Array
(
[id] => 13549155
[patent_doc_number] => 20180326125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Bio-Material Composition and Method for Preserving Motion in a Bone
[patent_app_type] => utility
[patent_app_number] => 15/978570
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978570
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978570 | Bio-Material Composition and Method for Preserving Motion in a Bone | May 13, 2018 | Abandoned |
Array
(
[id] => 15990247
[patent_doc_number] => 20200170994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => SUBLINGUAL CANNABINOID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/613194
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613194 | SUBLINGUAL CANNABINOID COMPOSITIONS | May 10, 2018 | Abandoned |
Array
(
[id] => 13409927
[patent_doc_number] => 20180256506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => NEW HARD CAPSULES
[patent_app_type] => utility
[patent_app_number] => 15/976622
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/976622 | Hard capsules | May 9, 2018 | Issued |
Array
(
[id] => 13925899
[patent_doc_number] => 20190046465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => INDIVIDUALLY-PACKAGED WIPES FOR ENHANCING SEXUAL INTERCOURSE
[patent_app_type] => utility
[patent_app_number] => 15/976015
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/976015 | Individually-packaged wipes for enhancing sexual intercourse | May 9, 2018 | Issued |
Array
(
[id] => 15927695
[patent_doc_number] => 20200155481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => INTRAMUSCULAR ATOVAQUONE FOR MALARIA PROPHYLAXIS
[patent_app_type] => utility
[patent_app_number] => 16/610684
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610684
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610684 | INTRAMUSCULAR ATOVAQUONE FOR MALARIA PROPHYLAXIS | May 2, 2018 | Abandoned |
Array
(
[id] => 13519671
[patent_doc_number] => 20180311378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => SYNTHETIC PLATELETS
[patent_app_type] => utility
[patent_app_number] => 15/968062
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968062 | SYNTHETIC PLATELETS | Apr 30, 2018 | Abandoned |
Array
(
[id] => 16837718
[patent_doc_number] => 20210145730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/606167
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606167 | PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM | Apr 19, 2018 | Pending |
Array
(
[id] => 14990621
[patent_doc_number] => 20190314268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Mixture of Skin Oils
[patent_app_type] => utility
[patent_app_number] => 15/955517
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955517 | Mixture of Skin Oils | Apr 16, 2018 | Abandoned |
Array
(
[id] => 13618643
[patent_doc_number] => 20180360873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => INORGANIC NITRITE TO IMPROVE CARDIOPULMONARY HEMODYNAMICS
[patent_app_type] => utility
[patent_app_number] => 15/954304
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954304 | Inorganic nitrite to improve cardiopulmonary hemodynamics | Apr 15, 2018 | Issued |
Array
(
[id] => 13474917
[patent_doc_number] => 20180289001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => TREATING SEEDS, PLANTS, AND SOIL WITH ENCAPSULATED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/948018
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15948018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/948018 | TREATING SEEDS, PLANTS, AND SOIL WITH ENCAPSULATED COMPOSITION | Apr 8, 2018 | Pending |
Array
(
[id] => 19535603
[patent_doc_number] => 12128136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Compositions and methods for cardiac regeneration
[patent_app_type] => utility
[patent_app_number] => 16/499618
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 9803
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499618 | Compositions and methods for cardiac regeneration | Apr 1, 2018 | Issued |